In this issue:
Exercise program for metastatic breast cancer
Inavolisib-based therapy in PIK3CA-mutated advanced breast cancer
Camizestrant in postmenopausal oestrogen receptor+, HER2– advanced breast cancer
STRAT4 assay using fine-needle aspiration biopsy in resource-constrained setting
Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal early breast cancer
BCI in premenopausal early-stage hormone receptor+ breast cancer
Breast cancer in adolescents/young adults vs. older patients
Adjuvant pertuzumab and trastuzumab in early HER2+ breast cancer
Prediagnostic circulating inflammatory biomarkers for breast cancer prognosis
Single-dose vs. 6-monhtly adjuvant zoledronic acid in early breast cancer
Please login below to download this issue (PDF)